VMD-928

DB18052InvestigationalSmall molecule

VMD-928: Overview.

Formula / weight: C₃₁H₃₂N₄O₄ · 524.621 g/mol (avg)
Also known as: 4-((4-AMINO-3-(4-CYCLOHEXYLPIPERAZIN-1-YL)-9,10-DIOXO-9,10-DIHYDROANTHRACEN-1-YL)AMINO)BENZOIC ACID · 4-{[4-Amino-3-(4-cyclohexylpiperazin-1-yl)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}benzoic acid · BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)-
Code names: VMD-928

Resolves to

Compound

Structure

InChIKeyYLGUWQFLCMWHDK-UHFFFAOYSA-NSMILESNC1=C(C=C(NC2=CC=C(C=C2)C(O)=O)C2=C1C(=O)C1=CC=CC=C1C2=O)N1CCN(CC1)C1CCCCC1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of VMD-928, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.